No abstract available
Plain language summary
This cohort study examines the association of low-dose vs high-dose 5-fluorouracil with overall survival when used in triplet chemotherapy plus bevacizumab in patients from the metastatic colorectal cancer (CRC).
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
-
Bevacizumab* / administration & dosage
-
Bevacizumab* / therapeutic use
-
Colorectal Neoplasms* / drug therapy
-
Dose-Response Relationship, Drug
-
Female
-
Fluorouracil* / administration & dosage
-
Fluorouracil* / therapeutic use
-
Humans
-
Male
-
Middle Aged